Publications in VIVO

Co-author Network

Co-investigator Network

Anna Parks, MD

Person

Positions

Assistant Professor, University of Utah, Division of Hematology
Fellow (specialty or subspecialty), University of California, San Francisco

Location

Salt Lake City, UT

I am a physician investigator applying aging research methods to improve the care of older adults with non-malignant hematologic disease. I am an Assistant Professor and Director of Thrombosis in the Division of Hematology & Hematologic Malignancies and a Center on Aging faculty member at the University of Utah. I use qualitative methods, powerful observational datasets, and collaborations with translational scientists to improve shared decision-making for older adults with venous thromboembolism and other blood diseases. We focus both on traditional outcomes (e.g., major bleeding and mortality) and aging-centered outcomes (e.g., frailty and functional independence).

Clinical Disciplines

Beeson awardee GEMSSTAR awardee

Publications
Research
Other
View All

Selected Publications

article
1. Anticoagulant therapy in renal insufficiency theme: Anticoagulation in complex situations.. Thrombosis research. -. 2024
2. Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease.. Journal of thrombosis and haemostasis : JTH. 21:2953-2962. 2023
3. Blood Clots, or Thrombosis, in Patients With Cancer.. JAMA oncology. 9:-. 2023
4. Periprocedural Anticoagulation.. Annals of internal medicine. 176:ITC49-ITC64. 2023
5. Assessment of the Risk of Venous Thromboembolism in Nonhospitalized Patients With COVID-19.. JAMA network open. 6:-. 2023
6. Teaching a Deeper Understanding of the Medical Literature.. Journal of general internal medicine. 38:1059-1060. 2022
7. Health-related quality of life associated with warfarin and direct oral anticoagulants in venous thromboembolism.. Thrombosis research. 97-102. 2022
8. What Can At-home Genetic Tests Tell Me About My Health?. JAMA internal medicine. 182:-. 2022
9. Venous thromboembolism (VTE) prevention and diagnosis in COVID-19: Practice patterns and outcomes at 33 hospitals.. PloS one. 17:-. 2022
10. Long-term functional outcomes and mortality after hospitalization for extracranial hemorrhage.. Journal of hospital medicine. 17:235-242. 2022
11. Persistent Gender Pay Gaps in Medicine: What Is Good for the Goose Is Better for the Gander's Paycheck.. JAMA internal medicine. 181:-. 2021
12. Anticoagulation at the End of Life: Time for a Rational Framework.. JAMA internal medicine. 181:-. 2021
13. An Elusive Seizure.. The Neurohospitalist. 12:188-194. 2021
14. Long-term individual and population functional outcomes in older adults with atrial fibrillation.. Journal of the American Geriatrics Society. 69:1570-1578. 2021
15. Incidence, management and outcomes of arterial and venous thrombosis after chimeric antigen receptor modified T cells for B cell lymphoma and multiple myeloma.. Leukemia & lymphoma. 62:1003-1006. 2020
16. Long-term individual and population functional outcomes in older adults with atrial fibrillation.. medRxiv : the preprint server for health sciences. 2020
17. Succeeding in Aging Research During the Pandemic: Strategies for Fellows and Junior Faculty.. Journal of the American Geriatrics Society. 69:8-11. 2020
18. COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic.. Thrombosis research. 355-358. 2020
19. Refining Risk for Deep Vein Thrombosis in Hospitalized Patients.. Journal of general internal medicine. 33:-. 2018
20. Dabigatran Compared With Rivaroxaban vs Warfarin-Reply.. JAMA internal medicine. 177:-. 2017
21. Scoring Systems for Estimating the Risk of Anticoagulant-Associated Bleeding.. Seminars in thrombosis and hemostasis. 43:514-524. 2017
22. Applying Academic Detailing and Process Change to Promote Choosing Wisely-Reply.. JAMA internal medicine. 177:-. 2017
23. Women in Medicine and Patient Outcomes: Equal Rights for Better Work?. JAMA internal medicine. 177:-. 2017
24. Comparing Non-Vitamin K Oral Anticoagulants: Where We Are Now.. JAMA internal medicine. 176:-. 2016
25. From Choosing Wisely to Practicing Value-More to the Story.. JAMA internal medicine. 176:1571-1572. 2016
26. Anticoagulation in the Very Old.. JAMA internal medicine. 176:-. 2016
27. Anticoagulation in Older Adults with Multimorbidity.. Clinics in geriatric medicine. 32:331-46. 2016
28. Teaching High-Value Care on Rounds: Modeling Moderation.. JAMA internal medicine. 176:262-3. 2016
29. Cases of spontaneous tumor regression in hepatobiliary cancers: implications for immunotherapy?. Journal of gastrointestinal cancer. 46:161-5. 2015
30. Male obesity and alteration in sperm parameters.. Fertility and sterility. 90:2222-5. 2008